Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Grégory Catteau"'
Autor:
Adriana Bastidas, Lars Rombo, Bruno Salaun, Andrew Hastie, Karlis Pauksens, Adaora Enemuo, Jan Smetana, Tomas Mrkvan, Caroline Hervé, Anne Schuind, Grégory Catteau, Stephanie Volpe, Tino F. Schwarz
Publikováno v:
The Journal of Infectious Diseases
Background The adjuvanted recombinant zoster vaccine (RZV) is highly immunogenic and efficacious in adults ≥50 years of age. We evaluated (1) long-term immunogenicity of an initial 2-dose RZV schedule, by following up adults vaccinated at ≥60 yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e595647a35a971af6f1c641cc0573415
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-427103
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-427103
Autor:
Grégory Catteau, Himal Lal, Tino F. Schwarz, Stéphanie Ravault, Gerard J. B. Sonder, Lars Rombo, Karlis Pauksens, Marie Pierre David, Lidia Oostvogels, Thomas C. Heineman, Jan Hendrik Richardus, Roman Chlibek, Jan Smetana, Adriana Bastidas, Stephanie Volpe
Publikováno v:
Human Vaccines & Immunotherapeutics, 14(6), 1370-1377. Landes Bioscience
Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics
Background: In adults aged ≥60 years, two doses of the herpes zoster subunit vaccine (HZ/su; 50 µg varicella-zoster virus glycoprotein E [gE] and AS01B Adjuvant System) elicited humoral and cell-mediated immune responses persisting for at least si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::981a84c8abb9e50ec6566512b29e6c39
https://pure.eur.nl/en/publications/18f4b5ef-5e7a-446d-94eb-9af7fdf4e614
https://pure.eur.nl/en/publications/18f4b5ef-5e7a-446d-94eb-9af7fdf4e614
Autor:
Anne Schuind, Jan Smetana, Lars Rombo, Stephanie Volpe, Tomas Mrkvan, Adaora Enemuo, Karlis Pauksens, Lidia Oostvogels, Tino F. Schwarz, Estelle Berengier, Caroline Hervé, Grégory Catteau, Adriana Bastidas
Publikováno v:
Open Forum Infectious Diseases
Background The adjuvanted recombinant zoster vaccine (RZV, GSK), administered to adults ≥ 50 years of age (YOA) demonstrated ≥ 90% efficacy against herpes zoster across all age cohorts. Vaccine-specific immune responses elicited by two RZV doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b3239c1a6747dd565e839ae226c0c74
http://europepmc.org/articles/PMC6808880
http://europepmc.org/articles/PMC6808880
Autor:
Frank Struyf, Mark H. Einstein, Philippe Moris, Bradley Fox, Karen G. Swenson, Myron J. Levin, Bethany Hoffman, Marina Fernandez, Nahida Chakhtoura, Robert Yoachim, Grégory Catteau, Lan Lin, Mark M. Blatter, Cheryl A. Hansen, Sidney A. Funk, Archana Chatterjee, Terry D. Klein, David L. Fried, Mark Turner, Jacob Lalezari, Peter Takacs, Michael J. Noss, Michael W. Warren, Francis Dessy, Troy Thompson, Christopher V. Chambers, Rhoda S. Sperling, James H. Silverblatt, Gary Dubin, James Hedrick
Publikováno v:
Human Vaccines & Immunotherapeutics
We previously reported higher anti-HPV-16 and -18 immune responses induced by HPV-16/18 vaccine compared with HPV-6/11/16/18 vaccine at Month 7 (one month after completion of full vaccination series) in women aged 18–45 y in an observer-blind study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e70f8ea7f27b1f2c0f0175b63656778a
https://doi.org/10.4161/hv.36117
https://doi.org/10.4161/hv.36117
Autor:
Grégory Catteau, Nervo Sanchez, Toufik Zahaf, Newton Sérgio de Carvalho, Dominique Descamps, Julio Cesar Teixeira, Paulo Naud, Brecht Geeraerts, Paola Colares de Borba, Cecilia Roteli-Martins
Publikováno v:
Human Vaccines & Immunotherapeutics
HPV-023 (NCT00518336; ClinicalTrial.gov) is a long-term follow-up of an initial double-blind, randomized (1:1), placebo-controlled study (HPV-001, NCT00689741) evaluating the efficacy against human papillomavirus (HPV)-16/18 infection and associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1b4d5acd36773ab8a4a8e61c3473e0
https://doi.org/10.4161/hv.29532
https://doi.org/10.4161/hv.29532
Autor:
F. Xavier Bosch, Dan Apter, Jorge Salmerón, Frank Struyf, Julio Cesar Teixeira, S. Rachel Skinner, Newton Sérgio de Carvalho, Dominique Descamps, Maria Julieta V Germar, Willy Poppe, Suzanne M. Garland, Paulo Naud, Grégory Catteau, Matti Lehtinen, Klaus Peters, M. Rowena Del Rosario-Raymundo, Unnop Jaisamrarn, Xavier Castellsagué, Gary Dubin, Genara Limson, James Hedrick, Jorma Paavonen, Song-Nan Chow, Tino F. Schwarz
Publikováno v:
International Journal of Cancer
We evaluated the efficacy of the human papillomavirus (HPV)−16/18 AS04‐adjuvanted vaccine in preventing HPV‐related disease after surgery for cervical lesions in a post‐hoc analysis of the PApilloma TRIal against Cancer In young Adults (PATRI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61fc29488a4d53751e2edad1cb282dc7
https://lirias.kuleuven.be/handle/123456789/553379
https://lirias.kuleuven.be/handle/123456789/553379
Autor:
Grégory Catteau, Georg Plassmann, Lars Rombo, Gini G. C. Van Rijckevorsel, Roman Chlibek, Jan Hendrik Richardus, Karlis Pauksens, Tino F. Schwarz, Himal Lal, Thomas C. Heineman
Publikováno v:
Vaccine, 34(6), 863-868. Elsevier
Background: An investigational subunit vaccine containing the varicella-zoster virus (VZV) glycoprotein E (gE) and the AS01(B) adjuvant system is being evaluated for the prevention of herpes zoster (HZ) in older adults. A phase II trial evaluating di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::520ae3322c5df75092cd7039a87c4759
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-280259
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-280259
Autor:
Michael E. Pichichero, Michael W. Simon, Gary S. Marshall, Bryan M. Harvey, Gary Dubin, Anne Schuind, Dominique Descamps, Stephen P. Combs, Cosette M. Wheeler, Grégory Catteau, Mark M. Blatter, Kurt Dobbelaere
Publikováno v:
Pediatric Infectious Disease Journal. 30:e225-e234
A combined immunization strategy for administration of human papillomavirus (HPV) vaccine with other routine vaccines may lead to better compliance. Reactions and immunologic interference with concomitantly administered vaccines are unpredictable, ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f70b883ba6525fabaaaecb38f578c4d
https://doi.org/10.1097/inf.0b013e31822d28df
https://doi.org/10.1097/inf.0b013e31822d28df
Autor:
Karin Schulze, Linda Ferguson, Brian Ramjattan, Tino F. Schwarz, Anne Schuind, Grégory Catteau, Klaus Peters, Kurt Dobbelaere, Dominique Descamps, Barbara Romanowski, Marc Dionne, Peter Hillemanns
Publikováno v:
Human Vaccines. 7:1374-1386
The immunogenicity of the human papillomavirus (HPV)-16/18 AS 04-adjuvanted vaccine (Cervarix®, GlaxoSmithKline Biologicals) administered according to its licensed vaccination schedule (3-dose, 3D) and formulation (20 µg of each HPV antigen; 20/20F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::552774e352c6fba77527922be2b28d17
https://doi.org/10.4161/hv.7.12.18322
https://doi.org/10.4161/hv.7.12.18322
Autor:
Jacek Wysocki, Tino F. Schwarz, Dominique Descamps, Karin Schulze, Grégory Catteau, Achim Schneider, Marek Spaczyński, Florence Thomas, Andrzej Galaj, Sylviane Poncelet
Publikováno v:
Human Vaccines. 7:958-965
The HPV-16/18 AS04-adjuvanted vaccine (Cervarix®, GlaxoSmithKline Biologicals) has been shown to induce a robust immune response in women aged 15–55 years (103514/NCT00196937). This follow-up study is the first report of persistence of immune resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85a0082fe330afe2e25728994feb5897
https://doi.org/10.4161/hv.7.9.15999
https://doi.org/10.4161/hv.7.9.15999